#zafgen

[worldfinancialdata-blog]

Zafgen (Nasdaq:ZFGN) is a clinical-stage biopharmaceutical company developing potentially transformative therapies for patients affected by a range

[healthaim]

Obesity Treatment: Zafgen's New Drug Succeeds In Mid-Stage Trial For Obesity treatment, Zafgen’s new drug has succeeded in mid stage clinical trial. Zafgen’s controversial obesity drug reduced the weight of overweight diabetic patients, the second trial success in as many months for the drug on which all tests have been halted since December after... http://www.healthaim.com/obesity-treatment-zafgens-new-drug-succeeds-mid-stage-trial/41409

Obesity Treatment: Zafgen's New Drug Succeeds In Mid-Stage Trial - http://www.healthaim.com/obesity-treatment-zafgens-new-drug-succeeds-mid-stage-trial/41409

For Obesity treatment, Zafgen’s new drug has succeeded in mid stage clinical trial. Zafgen’s controversial obesity drug reduced the weight of overweight diabetic patients, the second trial success in as many months for the drug on which all tests have been halted since December after...

[inndaily-blog]

Zafgen Shares Nearly Double on Obesity Treatment http://investingnews.com/daily/life-science-investing/pharmaceutical-investing/zafgen-shares-nearly-double-on-obesity-treatment/

Zafgen Shares Nearly Double on Obesity Treatment

Zafgen saw its share price almost double on Wednesday, after positive data on its experimental obesity drug could convince the US Food and Drug Administration to lift a hold

[steinmeyerlaw-blog]

Zafgen Inc. (ZFGN)

Zafgen Inc. (ZFGN)  — Steinmeyer Securities Litigation Group (SSLG) announces an investigation on behalf of Zafgen, Inc. investors (“Zafgen” or the “Company”) (Nasdaq: ZFGN) concerning the Company’s and its officers’ possible violations of federal securities laws. On October 16, 2015, Zafgen disclosed that it received verbal notice from the U.S. Food and Drug Administration that the clinical…

View On WordPress